Axsome Therapeutics, Inc.

AXSM 10-Q · Q1 2026
API behind this page

AXSM Q1 2026 request

Playground key active
Request URL /api/financials?ticker=AXSM&year=2026&quarter=1
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue 191,203 121,463 +57.4%
Show Product Lines breakouts
Milestone Revenue 1,803 1,105 +63.2%
Milestone Revenue · Auvelity 500 — —
Milestone Revenue · Non Us 1,303 1,105 +17.9%
Milestone Revenue · US 500 — —
Product 189,400 120,358 +57.4%
Product · Auvelity 152,696 96,231 +58.7%
Product · Non Us 528 945 -44.1%
Product · Sunosi 32,631 24,127 +35.2%
Product · US 188,872 119,413 +58.2%
Royalty · Sunosi 1,303 1,105 +17.9%
Royalty · Sunosi 0.5 — —
Royalty · Symbravo 4,073 — —
Cost Of Goods And Service Excluding Depreciation Depletion And Amortization 14,725 9,789 +50.4%
Research & Development 52,677 44,785 +17.6%
Show Product Lines breakouts
Balipodect · Takeda Pharmaceutical Company Limited 10.4 — —
Show Capitalized Costs Of Unproved Properties Excluded From Amortization By Property Or Project breakouts
AXS-05 10,904 14,477 -24.7%
AXS-07 5,470 4,479 +22.1%
AXS-12 1,488 2,409 -38.2%
AXS-14 2,696 1,186 +127.3%
Solriamfetol 11,231 11,806 -4.9%
Selling, General & Administrative 184,996 120,787 +53.2%
Change In Fair Value Of Contingent Considerations 590 1,512 -61.0%
Amortization Of Intangible Assets 1,572 1,572 0.0%
Total Costs & Expenses 254,560 178,445 +42.7%
Operating Income -63,357 -56,982 -11.2%
Investment Income Net -1,185 -2,431 +51.3%
Income Before Taxes -64,542 -59,413 -8.6%
Net Income -64,542 -59,413 -8.6%
Show Equity Components breakouts
Retained Earnings -64,542 -59,413 -8.6%
EPS (Basic) -1.26 -1.22 -3.3%
EPS (Diluted) -1.26 -1.22 -3.3%
Wtd Avg Shares (Basic) 51,198,349 48,871,163 +4.8%
Wtd Avg Shares (Diluted) 51,198,349 48,871,163 +4.8%
Sales & Marketing 146,437 92,288 +58.7%
General & Administrative 22,024 11,650 +89.0%
Interest Expense -3,092 -5,258 +41.2%
Interest Income Operating 1,907 2,827 -32.5%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents 305,106 300,910 +1.4%
Accounts Receivable 251,062 161,398 +55.6%
Inventory 31,515 16,319 +93.1%
Prepaid Expenses & Other Current Assets 23,523 16,007 +47.0%
Total Current Assets 611,206 494,634 +23.6%
Non-Current Assets
Property, Plant & Equipment 567 773 -26.6%
Operating Lease Right-of-Use Assets 20,014 23,294 -14.1%
Goodwill 12,042 12,042 0.0%
Other Inventory Noncurrent 30,831 20,606 +49.6%
Total Assets 713,607 596,671 +19.6%
Intangible Assets 38,947 45,322 -14.1%
Other Assets
Intangible Assets Net Excluding Goodwill 38,947 45,322 -14.1%
Current Liabilities
Accounts Payable 106,702 85,659 +24.6%
Accounts Payable And Other Accrued Liabilities Current 250,731 149,199 +68.1%
Operating Lease Liability Current 628 454 +38.3%
Business Combination Contingent Consideration Liability Current 11,150 8,602 +29.6%
Show Business Acquisition breakouts
Sunosi 11.2 8.6 +30.2%
Current Portion of Long-Term Debt 70,000 — —
Total Current Liabilities 439,211 243,914 +80.1%
Non-Current Liabilities
Business Combination Contingent Consideration Liability Noncurrent 73,730 90,590 -18.6%
Show Business Acquisition breakouts
Sunosi 73.7 90.6 -18.7%
Long-Term Debt 117,850 181,377 -35.0%
Operating Lease Liabilities 22,385 23,905 -6.4%
Finance Lease Liability Noncurrent 5,844 3,680 +58.8%
Total Liabilities 659,020 543,466 +21.3%
Stockholders' Equity
Common Stock 5 5 0.0%
Additional Paid In Capital Common Stock 1,425,085 1,235,400 +15.4%
Retained Earnings -1,370,503 -1,182,200 -15.9%
Total Stockholders' Equity 54,587 53,205 +2.6%
Show Equity Components breakouts
Additional Paid In Capital 1,425,085 1,235,400 +15.4%
Common Stock 5 5 0.0%
Retained Earnings -1,370,503 -1,182,200 -15.9%
Total Liabilities & Equity 713,607 596,671 +19.6%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Net Income -64,542 -59,413 -8.6%
Stock-Based Compensation 23,438 23,308 +0.6%
Amortization Of Debt Discount Premium 159 667 -76.2%
Show Equity Components breakouts
Warrant 159 274 -42.0%
Depreciation 116 149 -22.1%
Non Cash Lease Expense 844 609 +38.6%
Finance Lease Right Of Use Asset Amortization 679 412 +64.8%
Change in Accounts Receivable -26,598 -19,396 -37.1%
Change in Inventory -3,110 -249 -1149.0%
Increase Decrease In Prepaid Expense And Other Assets Current -9,872 -4,029 -145.0%
Non Current Inventory And Other Assets -1,762 -955 -84.5%
Change in Accounts Payable 41,165 13,662 +201.3%
Increase Decrease In Other Accounts Payable And Accrued Liabilities 17,229 818 +2006.2%
Increase Decrease In Operating Lease Liability -608 208 -392.3%
Net Cash from Operations -20,700 -43,375 +52.3%
Investing Activities
Capital Expenditures -121 -338 +64.2%
Net Cash from Investing -121 -338 +64.2%
Financing Activities
Proceeds From Long Term Lines Of Credit 70,000 — —
Repayments Of Long Term Debt -70,000 — —
Finance Lease Principal Payments -672 -401 -67.6%
Proceeds From Issuance Of Common Stock 6,343 19,650 -67.7%
Payments Of Stock Issuance Costs -95 -393 +75.8%
Proceeds From Issuance Of Common Stock Upon Exercise Of Options And Under Employee Stock Purchase Plan 9,981 17,035 -41.4%
Payment Of Contingent Consideration -3,262 -2,285 -42.8%
Tax Withholding for Share Compensation -9,301 -4,336 -114.5%
Net Cash from Financing 2,994 29,270 -89.8%
Supplemental
Interest Paid 2,932 4,590 -36.1%
Right Of Use Asset Obtained In Exchange For Finance Lease Liability 3,433 1,532 +124.1%
Other Cash Flow
Net Change in Cash -17,827 -14,443 -23.4%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 305,106 300,910 +1.4%

Values in thousands USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key